Usage: Glipizide extended-release tablets are indicated for the management of type 2 diabetes mellitus. However, they are not recommended for treating type 1 diabetes or diabetic ketoacidosis.
Usage: Lactulose is indicated for the prevention and treatment of portal-systemic encephalopathy, including hepatic pre-coma and coma. It effectively reduces blood ammonia levels, improves mental state, and enhances EEG patterns, with a positive clinical response in about 75% of patients, often increasing protein tolerance.
Usage: Levocarnitine Oral Solution is indicated for treating primary systemic carnitine deficiency and secondary carnitine deficiency due to inborn metabolic errors, presenting with symptoms such as Reye-like encephalopathy, hypoketotic hypoglycemia, and cardiomyopathy. Treatment should be complemented with supportive care as needed.
Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose lives are significantly impaired despite standard care. Its use is based on effects on standing blood pressure, though clinical benefits have yet to be established. Continued use requires significant symptomatic improvement.
Usage: Ofloxacin otic solution 0.3% is indicated for treating Otitis Externa in patients 6 months and older and Chronic Suppurative Otitis Media in those 12 years and older. It is also used for Acute Otitis Media in pediatric patients 1 year and older with tympanostomy tubes, targeting specific bacteria.